130 related articles for article (PubMed ID: 8255780)
1. Oncogene activation of HIV-LTR-driven expression via the NF-kappa B binding sites.
Bruder JT; Heidecker G; Tan TH; Weske JC; Derse D; Rapp UR
Nucleic Acids Res; 1993 Nov; 21(22):5229-34. PubMed ID: 8255780
[TBL] [Abstract][Full Text] [Related]
2. Both PU.1 and nuclear factor-kappa B mediate lipopolysaccharide- induced HIV-1 long terminal repeat transcription in macrophages.
Lodie TA; Reiner M; Coniglio S; Viglianti G; Fenton MJ
J Immunol; 1998 Jul; 161(1):268-76. PubMed ID: 9647233
[TBL] [Abstract][Full Text] [Related]
3. The Ras-Raf pathway is activated in human immunodeficiency virus-infected monocytes and particpates in the activation of NF-kappa B.
Folgueira L; Algeciras A; MacMorran WS; Bren GD; Paya CV
J Virol; 1996 Apr; 70(4):2332-8. PubMed ID: 8642660
[TBL] [Abstract][Full Text] [Related]
4. Differential regulation of the HIV-1 LTR by specific NF-kappa B subunits in HSV-1-infected cells.
Schafer SL; Hiscott J; Pitha PM
Virology; 1996 Oct; 224(1):214-23. PubMed ID: 8862416
[TBL] [Abstract][Full Text] [Related]
5. Kappa B site-dependent induction of gene expression by diverse inducers of nuclear factor kappa B requires Raf-1.
Finco TS; Baldwin AS
J Biol Chem; 1993 Aug; 268(24):17676-9. PubMed ID: 8349650
[TBL] [Abstract][Full Text] [Related]
6. Raf-1 kinase targets GA-binding protein in transcriptional regulation of the human immunodeficiency virus type 1 promoter.
Flory E; Hoffmeyer A; Smola U; Rapp UR; Bruder JT
J Virol; 1996 Apr; 70(4):2260-8. PubMed ID: 8642652
[TBL] [Abstract][Full Text] [Related]
7. Hypoxic activation of nuclear factor-kappa B is mediated by a Ras and Raf signaling pathway and does not involve MAP kinase (ERK1 or ERK2).
Koong AC; Chen EY; Mivechi NF; Denko NC; Stambrook P; Giaccia AJ
Cancer Res; 1994 Oct; 54(20):5273-9. PubMed ID: 7923153
[TBL] [Abstract][Full Text] [Related]
8. Differential effects of I kappa B molecules on Tat-mediated transactivation of HIV-1 LTR.
Harhaj E; Blaney J; Millhouse S; Sun SC
Virology; 1996 Feb; 216(1):284-7. PubMed ID: 8615004
[TBL] [Abstract][Full Text] [Related]
9. The c-rel protooncogene product represses NF-kappa B p65-mediated transcriptional activation of the long terminal repeat of type 1 human immunodeficiency virus.
Doerre S; Sista P; Sun SC; Ballard DW; Greene WC
Proc Natl Acad Sci U S A; 1993 Feb; 90(3):1023-7. PubMed ID: 8430069
[TBL] [Abstract][Full Text] [Related]
10. Raf-1 protein kinase activates the NF-kappa B transcription factor by dissociating the cytoplasmic NF-kappa B-I kappa B complex.
Li S; Sedivy JM
Proc Natl Acad Sci U S A; 1993 Oct; 90(20):9247-51. PubMed ID: 8415686
[TBL] [Abstract][Full Text] [Related]
11. The protein tyrosine kinase Fyn activates transcription from the HIV promoter via activation of NF kappa B-like DNA-binding proteins.
Hohashi N; Hayashi T; Fusaki N; Takeuchi M; Higurashi M; Okamoto T; Semba K; Yamamoto T
Int Immunol; 1995 Nov; 7(11):1851-9. PubMed ID: 8580083
[TBL] [Abstract][Full Text] [Related]
12. Integrin signaling to NF-kappa B in monocytic leukemia cells is blocked by activated oncogenes.
Rosales C; Juliano R
Cancer Res; 1996 May; 56(10):2302-5. PubMed ID: 8625304
[TBL] [Abstract][Full Text] [Related]
13. Essential role of NF-kappa B in transactivation of the human immunodeficiency virus long terminal repeat by the human cytomegalovirus 1E1 protein.
Kim S; Yu SS; Kim VN
J Gen Virol; 1996 Jan; 77 ( Pt 1)():83-91. PubMed ID: 8558131
[TBL] [Abstract][Full Text] [Related]
14. Analysis of the HIV-1 LTR NF-kappaB-proximal Sp site III: evidence for cell type-specific gene regulation and viral replication.
McAllister JJ; Phillips D; Millhouse S; Conner J; Hogan T; Ross HL; Wigdahl B
Virology; 2000 Sep; 274(2):262-77. PubMed ID: 10964770
[TBL] [Abstract][Full Text] [Related]
15. Activation of the human immunodeficiency virus type I long terminal repeat by 1 alpha,25-dihydroxyvitamin D3.
Nevado J; Tenbaum SP; Castillo AI; Sánchez-Pacheco A; Aranda A
J Mol Endocrinol; 2007 Jun; 38(6):587-601. PubMed ID: 17556530
[TBL] [Abstract][Full Text] [Related]
16. Cooperative inhibition of NF-kappa B and Tat-induced superactivation of human immunodeficiency virus type 1 long terminal repeat.
Biswas DK; Ahlers CM; Dezube BJ; Pardee AB
Proc Natl Acad Sci U S A; 1993 Dec; 90(23):11044-8. PubMed ID: 8248210
[TBL] [Abstract][Full Text] [Related]
17. Modulation of HIV-LTR activity by ras oncogenes.
Lembo D; Angeretti A; Gaboli M; Cavallo R; Landolfo S
New Microbiol; 1995 Apr; 18(2):111-6. PubMed ID: 7603337
[TBL] [Abstract][Full Text] [Related]
18. Involvement of Ets, rel and Sp1-like proteins in lipopolysaccharide-mediated activation of the HIV-1 LTR in macrophages.
Sweet MJ; Stacey KJ; Ross IL; Ostrowski MC; Hume DA
J Inflamm; 1998; 48(2):67-83. PubMed ID: 9656143
[TBL] [Abstract][Full Text] [Related]
19. Differences in transcriptional enhancers of HIV-1 and HIV-2. Response to T cell activation signals.
Tong-Starksen SE; Welsh TM; Peterlin BM
J Immunol; 1990 Dec; 145(12):4348-54. PubMed ID: 2258623
[TBL] [Abstract][Full Text] [Related]
20. NF-IL6-mediated transcriptional activation of the long terminal repeat of the human immunodeficiency virus type 1.
Tesmer VM; Rajadhyaksha A; Babin J; Bina M
Proc Natl Acad Sci U S A; 1993 Aug; 90(15):7298-302. PubMed ID: 8346247
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
